Article Text

PDF

P8
THE INHIBITORY EFFECT OF REMOTE ISCHAEMIC CONDITIONING ON A CELLULAR MODEL OF CARDIAC HYPERTROPHY
  1. A P Vanezis*,
  2. S A Edroos,
  3. N J Samani,
  4. G C Rodrigo
  1. University of Leicester Cardiovascular Sciences Department, Clinical Science Wing, Glenfield Hospital, Leicester, LE3 9QP

    Abstract

    Remote ischaemic conditioning (RIC) protects against ischaemia-reperfusion injury, but it is unclear whether it could also attenuate adverse cardiac remodelling post-MI. We hypothesised that RIC generates a blood born signal capable of reducing the hypertrophic response by modulating gene expression associated with remodelling.

    Superfusate was collected from ischaemic conditioned Langendorff perfused rat hearts (RIC-superfusate). Blood was taken from healthy volunteers after three cycles of upper arm conditioning (RIC-serum). The RIC-superfusate/serum was applied to H9c2 cardiomyoblasts in culture treated with endothelin-1 (ET-1) to stimulate hypertrophy. Immunofluorescence was used to determine cell area. Expression of four genes associated with cardiac remodelling: BNP, α-actin, βMHC and ms−1 were determined using qRT-PCR. Response was compared to saline/unconditioned serum.

    ET-1 (100 ng/ml) caused a significant degree of cellular hypertrophy after 48 h: 22.8±1.1 vs 16.4±0.7 mm2 in untreated cells (n=300 p<0.01). Pre-treatment with RIC-superfusate/RIC-serum significantly reduced ET-1 induced hypertrophy from 19.8±0.8 to 14.7±0.6mm2 and 23.6±1.5 to 16.1±1.1mm2 respectively (n=300 p<0.01). RIC-superfusate caused a significant decrease in ET-1 induced expression of α-actin (fold-change 8.0±0.4 to 1.7±0.1, n=4 p<0.01), βMHC (6.5±0.5 to 2.5±0.3, n=4 p<0.01), BNP (1.3±0.3 to 0.4±0.2, n=4 p<0.05) and ms−1 (31.6±2.7 to 13.0±1.4, n=4 p<0.01) after 48 h. RIC-serum significantly reduced ET-1 induced expression of βMHC (7.7±1.0 to 3.9±0.5, n=4 p<0.05) and ms−1 (15.4±2.7 to 7.0±0.7, n=4 p<0.05) after 48 h.

    Our data supports the hypothesis that RIC initiated humoral signalling may attenuate the deleterious process of cardiac remodelling. The findings identify a new therapeutic approach that may be beneficial in reducing adverse ventricular hypertrophy post-MI.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.